Clinical trial Recruiting at 1 site Interventional Ages 12 and up

Using magnetic stimulation to improve muscle function in spinal muscular atrophy

Official title: Safety and Tolerability of Low Motoneuron Stimulation Via Transcranial Magnetic Stimulation in Spinal Muscular Atrophy

Run by Charitable Foundation Children with Spinal Muscular Atrophy · NCT06977269 · Data updated 2026-11-12

This study is testing whether a type of brain stimulation can help improve muscle function in people with spinal muscular atrophy without them having to do any physical exercise.

Quick facts

Study typeInterventional
Ages12 Years and up
SexAll
Enrollment20 (estimated)
SponsorCharitable Foundation Children with Spinal Muscular Atrophy
Academic / other
Locations1 site (Kharkiv, Kharkiv Oblast)
StatusRecruiting
StartedMay 19, 2025
Main results expectedDecember 2025
Study endsJanuary 2026
Registry record updatedJune 18, 2025
Trial IDNCT06977269 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals diagnosed with 5q-autosomal recessive SMA who can perform minimal hand functions.

Probably not a fit

Patients with severe joint contractures or significant cognitive and behavioral issues may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the safety and tolerability of low motoneuron stimulation using transcranial magnetic stimulation (TMS) in patients with spinal muscular atrophy (SMA). The approach aims to mimic the effects of physical exercise, which can be challenging for SMA patients due to physical and psychological limitations. By applying high-frequency repetitive TMS, the study seeks to engage weak muscle groups and provide therapeutic benefits without requiring active participation from the patients. The study includes specific eligibility criteria to ensure that participants can safely engage with the intervention.

Why it matters

Potential benefit: If successful, this approach could enhance muscle function and overall quality of life for patients with spinal muscular atrophy.

How similar studies have gone: While the use of TMS in this context is innovative, previous studies have shown promise in using similar approaches for neuromuscular conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Subject has a diagnosis of 5q-autosomal recessive SMA confirmed by DNA test.
* Informed consent.
* A minimum score of 1 for Entry Item "A" of the Revised Upper Limb Module (RULM) scale for SMA: "Can use hands to hold pencil or pick up a coin/token or drive a powered chair, use phone key pad"

Exclusion Criteria:

* Subject has severe joint contractures that would affect ability to perform study measures, determined by the study physician.
* Subject has a deconditioned respiratory system, per the discretion of the physician investigator.
* Subject has behavioral or cognitive problems that preclude participation in the study, in the opinion of the investigator.

Where it's running

  • P.V. Voloshyn Institute of Neurology, Psychiatry and Narcology of the National Academy of Medical Sciences of Ukraine
    Kharkiv, Kharkiv Oblast, Ukraine
    Recruiting

Study contacts

  • Principal investigator: Olena V Pisotska, MD, PhD — P.V. Voloshyn Institute of Neurology, Psychiatry and Narcology of the National Academy of Medical Sciences of Ukraine
  • Study coordinator: Vitaliy M Matyushenko
  • Email: csma.ua@gmail.com
  • Phone: 380503640673

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.